Skip to main content

Advertisement

ADVERTISEMENT

HIV PrEP News

News
05/19/2020
“For Medicare beneficiaries with HIV, high out-of-pocket cost may be associated with decreased treatment adherence and with both individual- and population-level harm,” researchers of recent study explained.
“For Medicare beneficiaries with HIV, high out-of-pocket cost may be associated with decreased treatment adherence and with both individual- and population-level harm,” researchers of recent study explained.
“For Medicare beneficiaries with...
05/19/2020
First Report Managed Care

Advertisement

News
04/21/2020
Researchers compare the clinical and economical benefits of branded vs generic PrEP therapies for patients with HIV in a study published in Annals of Internal Medicine.
Researchers compare the clinical and economical benefits of branded vs generic PrEP therapies for patients with HIV in a study published in Annals of Internal Medicine.
Researchers compare the clinical...
04/21/2020
First Report Managed Care

Advertisement